Kirkland represented Thomas H. Lee Partners, L.P. (THL) and Frazier Healthcare Partners, which today announced they have acquired Adare Pharmaceuticals, which will be rebranded Adare Pharma Solutions, from TPG Capital. Adare is a leading specialty contract development and manufacturing organization (CDMO) and global provider of advanced pharmaceutical technologies. The acquisition includes Adare’s CDMO, pharmaceutical technology and microbiome businesses. TPG Capital will retain rights to Adare’s Eosinophilic Esophagitis (EoE) product, which has been spun out into a separate entity.
The Kirkland team was led by transactional partners Ted Frankel and Chris Elder and associate Andrew Struckmeyer, debt finance partner Eric Wedel and associate Matthew Leist, and tax partners Dean Shulman and Sehj Vather.